Pharmaceutical compounds
AssigneeBiovail Laboratories International (Barbados) S.R.L.
InventorPhilip Paul Nichols
Life of this patent
Estimating the term…
Abstract
This application describes method of treating dementia and cognitive deficits associated with dementia that involve administration of dihydrotetrabenazine, and isomers and/or pharmaceutically acceptable salts thereof.
Claims12
A method of treating dementia or a cognitive deficit associated with dementia in a patient in need thereof, which method comprises administering to the patient a therapeutically effective amount of a 3,11b-cis-dihydrotetrabenazine or a pharmaceutically acceptable salt thereof, to thereby treat dementia or a cognitive deficit associated with dementia in the patient.
The method of claim 9, wherein the salt is a methane sulphonate salt.
Dependencies are inferred from the claim text.